-
Letter to the Editor07-27-2021
Impact of the Covid-19 Pandemic on Birth Rates in 2020: The Case of Colombia
- Vicky Margarita Montaño Mendoza
, - Paula Andrea Velilla ,
- Sergio Tamayo Hussein ,
- Walter Cardona Maya
Abstract
Letter to the EditorImpact of the Covid-19 Pandemic on Birth Rates in 2020: The Case of Colombia
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):492-494
- Vicky Margarita Montaño Mendoza ,
- Paula Andrea Velilla ,
- Sergio Tamayo Hussein ,
- Walter Cardona Maya
Views131The global emergency arising from the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) virus, the etiological agent responsible for coronavirus disease 2019 (Covid-19), has resulted in a significant loss of more than 2.5 million human lives across the world until now. On March 12, 2020, Colombia’s authorities declared a state of […]See moreViews131
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Letter to the EditorImpact of the Covid-19 Pandemic on Birth Rates in 2020: The Case of Colombia
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):492-494
- Vicky Margarita Montaño Mendoza ,
- Paula Andrea Velilla ,
- Sergio Tamayo Hussein ,
- Walter Cardona Maya
Views131The global emergency arising from the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) virus, the etiological agent responsible for coronavirus disease 2019 (Covid-19), has resulted in a significant loss of more than 2.5 million human lives across the world until now. On March 12, 2020, Colombia’s authorities declared a state of […]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
- Vicky Margarita Montaño Mendoza
-
Letter to the Editor07-27-2021
Vaccine for Covid-19 and Pregnant Women
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):490-491
Abstract
Letter to the EditorVaccine for Covid-19 and Pregnant Women
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):490-491
Views96Dear Editor, We would like to share ideas on “We have Vaccine for Covid-19! What to Recommend for Pregnant Women?”1 Quintana1 concluded that “The final decision whether or not to receive the vaccine will be made by the woman after receiving the appropriate information. This same principle applies with even greater emphasis to puerperal and […]See moreViews96This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Letter to the EditorVaccine for Covid-19 and Pregnant Women
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):490-491
Views96Dear Editor, We would like to share ideas on “We have Vaccine for Covid-19! What to Recommend for Pregnant Women?”1 Quintana1 concluded that “The final decision whether or not to receive the vaccine will be made by the woman after receiving the appropriate information. This same principle applies with even greater emphasis to puerperal and […]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Letter to the Editor07-27-2021Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):490-491
Abstract
Letter to the EditorRevista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):490-491
Views79This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Letter to the EditorRevista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):490-491
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Letter to the Editor06-18-2021
Twelve Months Down the Line: do we know Anything more about the Presence of the SARS-CoV-2 in Human Semen?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(4):339-340
Abstract
Letter to the EditorTwelve Months Down the Line: do we know Anything more about the Presence of the SARS-CoV-2 in Human Semen?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(4):339-340
Views127Dear Editor, During the last year, the SARS-CoV-2 infectious agent of COVID-19 has caused more than 75 million infections and 1.5 million deaths worldwide. It has been observed to affect the respiratory tract and exert multiple effects on the human body, including the male reproductive tract. To date, it is understood that although the general […]See moreViews127This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Letter to the EditorTwelve Months Down the Line: do we know Anything more about the Presence of the SARS-CoV-2 in Human Semen?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(4):339-340
Views127Dear Editor, During the last year, the SARS-CoV-2 infectious agent of COVID-19 has caused more than 75 million infections and 1.5 million deaths worldwide. It has been observed to affect the respiratory tract and exert multiple effects on the human body, including the male reproductive tract. To date, it is understood that although the general […]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Letter to the Editor06-18-2021
- Daniel Lorber Rolnik ,
- Mario Henrique Burlacchini de Carvalho ,
- Guilherme Antonio Rago Lobo ,
- Stefan Verlohren ,
- Liona Poon , [ ... ],
- Fabricio da Silva Costa
Abstract
Letter to the EditorRevista Brasileira de Ginecologia e Obstetrícia. 2021;43(4):334-338
Views109This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Letter to the EditorRevista Brasileira de Ginecologia e Obstetrícia. 2021;43(4):334-338
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Daniel Lorber Rolnik
-
Letter to the Editor06-18-2021
Preeclampsia: Universal Screening or Universal Prevention for Low andMiddle-Income Settings?
- Daniel Lorber Rolnik ,
- Mario Henrique Burlacchini de Carvalho ,
- Guilherme Antonio Rago Lobo ,
- Stefan Verlohren ,
- Liona Poon , [ ... ],
- Fabricio da Silva Costa
Abstract
Letter to the EditorPreeclampsia: Universal Screening or Universal Prevention for Low andMiddle-Income Settings?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(4):334-338
- Daniel Lorber Rolnik ,
- Mario Henrique Burlacchini de Carvalho ,
- Guilherme Antonio Rago Lobo ,
- Stefan Verlohren ,
- Liona Poon ,
- Ahmet Baschat ,
- Jon Hyett ,
- Basky Thilaganathan ,
- Emmanuel Bujold ,
- Fabricio da Silva Costa
Views113Dear Editor, We read with interest the Clinical Consensus Recommendation about screening and prevention of preeclampsia published by De Oliveira et al. The authors recommend that identification of high-risk women should be based on maternal risk factors alone, and that universal treatment (of all pregnant women) with aspirin at a dose of 100 mg should be […]See moreViews113This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Letter to the EditorPreeclampsia: Universal Screening or Universal Prevention for Low andMiddle-Income Settings?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(4):334-338
- Daniel Lorber Rolnik ,
- Mario Henrique Burlacchini de Carvalho ,
- Guilherme Antonio Rago Lobo ,
- Stefan Verlohren ,
- Liona Poon ,
- Ahmet Baschat ,
- Jon Hyett ,
- Basky Thilaganathan ,
- Emmanuel Bujold ,
- Fabricio da Silva Costa
Views113Dear Editor, We read with interest the Clinical Consensus Recommendation about screening and prevention of preeclampsia published by De Oliveira et al. The authors recommend that identification of high-risk women should be based on maternal risk factors alone, and that universal treatment (of all pregnant women) with aspirin at a dose of 100 mg should be […]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Daniel Lorber Rolnik
-
Letter to the Editor05-24-2021
COVID-19 in Brazil: A Message to the World
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(3):238-239
Abstract
Letter to the EditorCOVID-19 in Brazil: A Message to the World
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(3):238-239
Views103Dear Editor, Although the spread and severity of the Spanish Flu pandemic in 1918 have been much more significant than the numbers of COVID-19 so far, no one is able to affirm that the current crisis is nearing its end, and it is plausible to expect that it will overcome the “mother of all pandemics” […]See moreViews103This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Letter to the EditorCOVID-19 in Brazil: A Message to the World
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(3):238-239
Views103Dear Editor, Although the spread and severity of the Spanish Flu pandemic in 1918 have been much more significant than the numbers of COVID-19 so far, no one is able to affirm that the current crisis is nearing its end, and it is plausible to expect that it will overcome the “mother of all pandemics” […]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Letter to the Editor05-24-2021
Advanced Cervical Cancer: Leveraging the Historical Threshold of Overall Survival
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(3):235-237
Abstract
Letter to the EditorAdvanced Cervical Cancer: Leveraging the Historical Threshold of Overall Survival
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(3):235-237
Views96Dear Editor, Cervical cancer is a public health problem in low- and middle-income countries, where many patients are diagnosed at an advanced stage. After the Gynecology Oncology Group (GOG) 240 study, the first-line standard of care for patients in recurrent and/or metastatic settings includes the incorporation of bevacizumab with chemotherapy. Regarding the second line, no […]See moreViews96This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Letter to the EditorAdvanced Cervical Cancer: Leveraging the Historical Threshold of Overall Survival
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(3):235-237
Views96Dear Editor, Cervical cancer is a public health problem in low- and middle-income countries, where many patients are diagnosed at an advanced stage. After the Gynecology Oncology Group (GOG) 240 study, the first-line standard of care for patients in recurrent and/or metastatic settings includes the incorporation of bevacizumab with chemotherapy. Regarding the second line, no […]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Letter to the Editor Archives - Revista Brasileira de Ginecologia e Obstetrícia
